Nasdaq
$0.1018▼ 3.23%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $2.3MShares out 22.2M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
33- 10.13Pre-market26.10.13 19:194Ownership#●●●
Adagio Medical Holdings, Inc.
Insider Mirsaeedi-Farahani Keyvan of Adagio Medical Holdings, Inc. reported a change in beneficial ownership of securities effective September 27, 2024. This filing provides the details of the insider's equity transaction via Form 4.…more
$0.1018-3.23%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.13Pre-market26.10.13 19:02DEF 14AOther
Adagio Medical Holdings, Inc.
Adagio Medical Holdings will hold a special meeting of stockholders on October 23, 2026, to approve a reverse stock split of its common stock. The Board of Directors will be authorized to effect the reverse split at a ratio ranging from 1-for-10 to 1-for-500, at its sole discretion.…more
$0.1018-3.23%vs prev closeView filingShare - 10.1After-hours26.10.02 06:088-KKey event
Adagio Medical Holdings, Inc.
Adagio Medical Holdings issued 4,978,869 shares of common stock following the conversion of $776,111 in aggregate principal amount of its 13% senior secured convertible notes. The conversion was executed at prices ranging from $0.1265 to $0.1618 per share under the company's alternate conversion election.…more
$0.1018-3.23%vs prev closeView filingShare
32 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 9.23Pre-market26.09.23 21:05#●●●#●●●#●●●
Adagio Medical Initiates Strategic Review and Workforce Reduction
Adagio Medical has launched a formal process to explore strategic alternatives, including potential mergers or acquisitions, to maximize shareholder value. The company is also implementing a workforce reduction to align its cost structure with prioritized programs.…more
$0.1018-3.23%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 9.16Pre-market26.09.16 21:03
●●●●●●●● ●●●●● ●●●●●●
Adagio Medical has successfully treated the first patient in an IDE study for its next-generation vCLAS Ultra ventricular ablation system. This clinical milestone marks a key step in evaluating the safety and efficacy of the device for treating sustained monomorphic ventricular tachycardia.…more
$0.1018-3.23%vs prev closeShareBenzinga
1 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report